This Enzyme Is the New Focus for Cancer Treatment
- Data presented at big cancer meeting gets ‘a lot of buzz’
- Small co. Incyte leads research with drug inhibiting enzyme
This article is for subscribers only.
For a fetus in the womb, it’s an enzyme that means life, a shield from a mother’s immune system that would otherwise fight the embryo as an infection. Gone rogue, it can mean death -- protecting malignant tumors from attacks by the body’s defenses.
That enzyme, IDO, is now the target of the next wave of cancer research.